JP2009531450A5 - - Google Patents

Download PDF

Info

Publication number
JP2009531450A5
JP2009531450A5 JP2009503166A JP2009503166A JP2009531450A5 JP 2009531450 A5 JP2009531450 A5 JP 2009531450A5 JP 2009503166 A JP2009503166 A JP 2009503166A JP 2009503166 A JP2009503166 A JP 2009503166A JP 2009531450 A5 JP2009531450 A5 JP 2009531450A5
Authority
JP
Japan
Prior art keywords
compound
pharmaceutical composition
diclofenac
cyclodextrin
administered
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2009503166A
Other languages
English (en)
Japanese (ja)
Other versions
JP5823093B2 (ja
JP2009531450A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2007/064678 external-priority patent/WO2007112272A2/en
Publication of JP2009531450A publication Critical patent/JP2009531450A/ja
Publication of JP2009531450A5 publication Critical patent/JP2009531450A5/ja
Application granted granted Critical
Publication of JP5823093B2 publication Critical patent/JP5823093B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2009503166A 2006-03-28 2007-03-22 低投与量のジクロフェナク及びβ−シクロデキストリンの配合物 Expired - Fee Related JP5823093B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US78648606P 2006-03-28 2006-03-28
US60/786,486 2006-03-28
PCT/US2007/064678 WO2007112272A2 (en) 2006-03-28 2007-03-22 Formulations of low dose diclofenac and beta-cyclodextrin

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2013216668A Division JP6157305B2 (ja) 2006-03-28 2013-10-17 低投与量のジクロフェナク及びβ−シクロデキストリンの配合物

Publications (3)

Publication Number Publication Date
JP2009531450A JP2009531450A (ja) 2009-09-03
JP2009531450A5 true JP2009531450A5 (https=) 2011-09-29
JP5823093B2 JP5823093B2 (ja) 2015-11-25

Family

ID=38541808

Family Applications (3)

Application Number Title Priority Date Filing Date
JP2009503166A Expired - Fee Related JP5823093B2 (ja) 2006-03-28 2007-03-22 低投与量のジクロフェナク及びβ−シクロデキストリンの配合物
JP2013216668A Expired - Fee Related JP6157305B2 (ja) 2006-03-28 2013-10-17 低投与量のジクロフェナク及びβ−シクロデキストリンの配合物
JP2015241131A Expired - Fee Related JP6265964B2 (ja) 2006-03-28 2015-12-10 低投与量のジクロフェナク及びβ−シクロデキストリンの配合物

Family Applications After (2)

Application Number Title Priority Date Filing Date
JP2013216668A Expired - Fee Related JP6157305B2 (ja) 2006-03-28 2013-10-17 低投与量のジクロフェナク及びβ−シクロデキストリンの配合物
JP2015241131A Expired - Fee Related JP6265964B2 (ja) 2006-03-28 2015-12-10 低投与量のジクロフェナク及びβ−シクロデキストリンの配合物

Country Status (12)

Country Link
US (4) US8580954B2 (https=)
EP (3) EP2004203A4 (https=)
JP (3) JP5823093B2 (https=)
KR (5) KR20080112285A (https=)
CN (2) CN101410123A (https=)
AU (1) AU2007230716B2 (https=)
BR (1) BRPI0709409A2 (https=)
CA (1) CA2647348A1 (https=)
IL (2) IL194185A (https=)
MX (1) MX2008012495A (https=)
WO (1) WO2007112272A2 (https=)
ZA (1) ZA200808115B (https=)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8580954B2 (en) * 2006-03-28 2013-11-12 Hospira, Inc. Formulations of low dose diclofenac and beta-cyclodextrin
KR20090010953A (ko) * 2006-03-28 2009-01-30 자블린 파머슈티칼스 인코포레이티드 저 복용량의 비-스테로이드성 항염증성 약물 및 베타-사이클로덱스트린 제형
US9550827B2 (en) 2007-10-19 2017-01-24 The Regents Of The University Of California Methods for ameliorating and preventing central nervous system inflammation
EP2632553B1 (en) 2010-10-28 2020-01-01 Pacira Pharmaceuticals, Inc. A sustained release formulation of a non-steroidal anti-inflammatory drug
MY166036A (en) * 2011-07-20 2018-05-21 Hospira Inc Methods of treating pain
US20140275261A1 (en) 2013-03-15 2014-09-18 Dr. Reddy's Laboratories, Inc. Diclofenac parenteral compositions
CN107126418B (zh) * 2016-02-25 2020-05-29 江苏思邈医药科技有限公司 供注射用双氯芬酸钠药物组合物及其制备方法
EP3541815A4 (en) 2016-11-18 2020-07-15 Pacira Pharmaceuticals, Inc. ZINC MELXICAM COMPLEX MICROPARTICLE MULTIVESICULAR LIPOSOME FORMULATIONS AND METHODS OF MAKING THE SAME
US11110073B2 (en) 2017-03-24 2021-09-07 Cadila Healthcare Limited Storage stable aqueous injectable solution comprising diclofenac
GB201720992D0 (en) * 2017-12-15 2018-01-31 Hooper Mark A medical use
WO2021048748A1 (en) 2019-09-09 2021-03-18 Ftf Pharma Private Limited Pharmaceutical formulations comprising diclofenac
US11707443B2 (en) 2019-09-26 2023-07-25 Rk Pharma Inc. Storage stable aqueous parenteral solutions comprising diclofenac
US20240382597A1 (en) * 2021-12-31 2024-11-21 LIVIONEX, Inc. Formulations of anti-inflammatory agents comprising msm with enhanced solubility in water

Family Cites Families (137)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5984821U (ja) 1982-11-30 1984-06-08 日新電機株式会社 積層コイル
JPS59188644A (ja) 1983-04-09 1984-10-26 Fuji Photo Film Co Ltd 画像形成方法
US4727064A (en) 1984-04-25 1988-02-23 The United States Of America As Represented By The Department Of Health And Human Services Pharmaceutical preparations containing cyclodextrin derivatives
DE3446873A1 (de) 1984-12-21 1986-07-10 Merckle Gmbh Fluessige diclofenac-zubereitungen
GB8506792D0 (en) 1985-03-15 1985-04-17 Janssen Pharmaceutica Nv Derivatives of y-cyclodextrin
US5785989A (en) 1985-05-01 1998-07-28 University Utah Research Foundation Compositions and methods of manufacturing of oral dissolvable medicaments
US6407079B1 (en) 1985-07-03 2002-06-18 Janssen Pharmaceutica N.V. Pharmaceutical compositions containing drugs which are instable or sparingly soluble in water and methods for their preparation
JPS62138437U (https=) 1986-02-26 1987-09-01
YU43290B (en) 1986-11-13 1989-06-30 Lek Tovarna Farmacevtskih Process for preparing inclusioned complex of ibuproxane with beta-cyclodextrine
JPH0616547Y2 (ja) 1986-12-16 1994-05-02 ヒゲタ醤油株式会社 諸味揚槽用濾布
US5690954A (en) 1987-05-22 1997-11-25 Danbiosyst Uk Limited Enhanced uptake drug delivery system having microspheres containing an active drug and a bioavailability improving material
US5017566A (en) 1987-12-30 1991-05-21 University Of Florida Redox systems for brain-targeted drug delivery
US5002935A (en) 1987-12-30 1991-03-26 University Of Florida Improvements in redox systems for brain-targeted drug delivery
EP0335545B2 (en) 1988-03-29 1998-09-23 University Of Florida Pharmaceutical formulations for parenteral use
JP2575460B2 (ja) * 1988-05-12 1997-01-22 東京田辺製薬株式会社 ダナゾール−シクロデキストリン包接化合物
MY106598A (en) 1988-08-31 1995-06-30 Australian Commercial Res & Development Ltd Compositions and methods for drug delivery and chromatography.
IT1227626B (it) 1988-11-28 1991-04-23 Vectorpharma Int Farmaci supportati aventi velocita' di dissoluzione aumentata e procedimento per la loro preparazione
CH679277A5 (https=) 1989-02-09 1992-01-31 Sandoz Ag
IT1241417B (it) 1990-03-06 1994-01-14 Vectorpharma Int Composizioni terapeutiche a rilascio controllato di farmaci supportatisu polimeri reticolati e rivestiti con film polimerici,e loro processodi preparazione
IT1243342B (it) 1990-07-13 1994-06-10 Farcon Ag Composizioni farmaceutiche orali liquide ad attivita' antiinfiammatoria
JP3765579B2 (ja) 1990-08-24 2006-04-12 イーデーエーアー アーゲー 作用物質投与用超微小滴状調剤
EP1004318A3 (en) 1991-06-21 2002-08-07 Takeda Chemical Industries, Ltd. Cyclodextrin composition
DE4207922A1 (de) 1992-03-13 1993-09-23 Pharmatech Gmbh Wasserloesliche einschlussverbindungen und verfahren zu deren herstellung
IT1255522B (it) 1992-09-24 1995-11-09 Ubaldo Conte Compressa per impiego terapeutico atta a cedere una o piu' sostanze attive con differenti velocita'
US5811547A (en) 1992-10-14 1998-09-22 Nippon Shinyaju Co., Ltd. Method for inducing crystalline state transition in medicinal substance
US5389681A (en) 1992-10-22 1995-02-14 Ciba-Geigy Corporation Parenteral solutions for diclofenac salts
IT1256386B (it) 1992-11-13 1995-12-04 Luigi Boltri Composizioni farmaceutiche comprendenti un farmaco,una sostanza polimerica reticolata,un olio ed un agente tensioattivo
AU6971294A (en) 1993-06-08 1995-01-03 Novartis Ag Process for the preparation of an oral solid dosage form containing diclofenac
IT1264696B1 (it) 1993-07-09 1996-10-04 Applied Pharma Res Forme farmaceutiche destinate alla somministrazione orale in grado di rilasciare sostanze attive a velocita' controllata e differenziata
GB9316580D0 (en) 1993-08-10 1993-09-29 Smithkline Beecham Plc Pharmaceutical composition
US5866162A (en) 1993-08-10 1999-02-02 Smithkline Beecham P.L.C. Pharmaceutical composition containing a drug/β-cyclodextrin complex in combination with an acid-base couple
GB9318880D0 (en) 1993-09-11 1993-10-27 Smithkline Beecham Plc Pharmaceutical composition
IL111184A (en) 1993-10-08 2000-08-13 Farmarc Nederland B V Of Cito Crystalline inclusion complex of diclofenac with unsubstituted beta-cyclodextrin
US5540930A (en) 1993-10-25 1996-07-30 Pharmos Corporation Suspension of loteprednol etabonate for ear, eye, or nose treatment
WO1995013794A1 (en) 1993-11-18 1995-05-26 Nippon Shinyaku Co., Ltd. Process for producing stable medicinal composition, and pharmaceutical preparation
ZA949182B (en) 1993-12-02 1995-07-26 South African Druggists Ltd Pharmaceutical composition
US5464633A (en) 1994-05-24 1995-11-07 Jagotec Ag Pharmaceutical tablets releasing the active substance after a definite period of time
JPH10500982A (ja) 1994-05-27 1998-01-27 ファーマーク、ネダーランド、ベスローテン、フェンノートシャップ 医薬組成物
WO1996011003A1 (en) 1994-10-10 1996-04-18 Novartis Ag Ophthalmic and aural compositions containing diclofenac potassium
ZA959469B (en) 1994-11-15 1996-05-15 South African Druggists Ltd Pharmaceutical composition
ATE215821T1 (de) 1995-01-20 2002-04-15 Wakamoto Pharma Co Ltd Entzündungshemmende augentropfen
JP3934705B2 (ja) * 1995-05-26 2007-06-20 ノバルティス ファーマ株式会社 サイクロデキストリン組成物
US5747058A (en) 1995-06-07 1998-05-05 Southern Biosystems, Inc. High viscosity liquid controlled delivery system
US5821237A (en) 1995-06-07 1998-10-13 The Procter & Gamble Company Compositions for visually improving skin
IT1276689B1 (it) 1995-06-09 1997-11-03 Applied Pharma Res Forma farmaceutica solida ad uso orale
AU5774796A (en) 1995-06-13 1997-01-09 Dyer, Alison Margaret Pharmaceutical compositions containing lornoxicam and cyclod extrin
TW434023B (en) 1995-09-18 2001-05-16 Novartis Ag Preserved ophthalmic composition
HUP9600758A2 (en) 1996-03-27 1998-03-02 Cyclolab Ciklodextrin Kutato F Diclofenac composition of diminished gastrointestinal irritation and enhanced biological resorption
FR2751875B1 (fr) 1996-08-05 1998-12-24 Scr Newpharm Nouvelles formulations liquides stables a base de paracetamol et leur mode de preparation
EP0868915A1 (en) 1997-04-02 1998-10-07 Panacea Biotec Limited An anti-spasmodic and antiinflammatory composition containing a NSAID, pentifenone and fenpiverinium
IT1291362B1 (it) 1997-05-13 1999-01-07 Vectorpharma Int Composizioni farmaceutiche multicomponente bifasiche contenenti sostanze atte a modificare la partizione dei principi attivi
US6365180B1 (en) 1998-01-20 2002-04-02 Glenn A. Meyer Oral liquid compositions
EP1049459B1 (en) 1998-01-20 2009-04-22 Applied Analytical Industries, Inc. Oral liquid compositions
US7772220B2 (en) 2004-10-15 2010-08-10 Seo Hong Yoo Methods and compositions for reducing toxicity of a pharmaceutical compound
US6365182B1 (en) * 1998-08-12 2002-04-02 Cima Labs Inc. Organoleptically pleasant in-mouth rapidly disintegrable potassium chloride tablet
US6294192B1 (en) 1999-02-26 2001-09-25 Lipocine, Inc. Triglyceride-free compositions and methods for improved delivery of hydrophobic therapeutic agents
US6248363B1 (en) 1999-11-23 2001-06-19 Lipocine, Inc. Solid carriers for improved delivery of active ingredients in pharmaceutical compositions
US6383471B1 (en) 1999-04-06 2002-05-07 Lipocine, Inc. Compositions and methods for improved delivery of ionizable hydrophobic therapeutic agents
US7186260B2 (en) 1999-04-29 2007-03-06 Hyson Morton I Medicated wrap
US6313370B1 (en) 1999-04-29 2001-11-06 Morton Hyson Medicated wrap
ES2187234A1 (es) * 1999-04-30 2003-05-16 Lilly Icos Llc Forma de dosificacion oral para tratar la disfuncion sexual.
WO2000071098A1 (en) 1999-05-24 2000-11-30 Purepac Pharmaceutical Co. A pharmaceutical composition containing an active agent that is maintained in solid amorphous form and method of making the same
US6720001B2 (en) 1999-10-18 2004-04-13 Lipocine, Inc. Emulsion compositions for polyfunctional active ingredients
ATE283048T1 (de) 1999-12-08 2004-12-15 Pharmacia Corp Cyclooxygenase-2 hemmer enthaltende zusammensetzungen mit schnellem wirkungseintritt
KR100416242B1 (ko) 1999-12-22 2004-01-31 주식회사 삼양사 약물전달체용 생분해성 블록 공중합체의 액체 조성물 및이의 제조방법
AU4866001A (en) 2000-03-28 2001-10-08 Farmarc Nederland Bv Alprazolam inclusion complexes and pharmaceutical compositions thereof
WO2001098329A1 (en) 2000-06-22 2001-12-27 Theravance, Inc. Polyhydroxy glycopeptide derivatives
PE20020146A1 (es) 2000-07-13 2002-03-31 Upjohn Co Formulacion oftalmica que comprende un inhibidor de ciclooxigenasa-2 (cox-2)
CN1729002A (zh) 2000-09-08 2006-02-01 法玛西雅意大利公司 依西美坦作为化学预防剂
EP1219304B1 (de) 2000-12-28 2004-10-20 Fresenius Kabi Austria GmbH Stabile Infusionslösung von Diclofenac-Salzen, deren Herstellung und Verwendung
EP1219306A1 (en) 2000-12-29 2002-07-03 Nicox S.A. Compositions comprising cyclodextrins and NO- releasing drugs
JP2004519490A (ja) 2001-01-26 2004-07-02 フアルマシア・イタリア・エツセ・ピー・アー エキセメスタンによるホルモン依存性異常症の組合せ治療方法
JP2004525798A (ja) * 2001-03-28 2004-08-26 バイエル アクチェンゲゼルシャフト 情報層中に吸光性化合物としてシアニン色素を含有する光学データ記録媒体
US20080220441A1 (en) 2001-05-16 2008-09-11 Birnbaum Eva R Advanced drug development and manufacturing
US20040137062A1 (en) 2001-05-25 2004-07-15 Sham Chopra Chronotherapy tablet and methods related thereto
SE0102855D0 (sv) * 2001-08-27 2001-08-27 Astrazeneca Ab Method of treatment
FR2830017B1 (fr) 2001-09-27 2005-11-04 Centre Nat Rech Scient Materiau compose d'au moins un polymere biodegradable et de cyclodextrines
EP1443969A2 (en) 2001-10-18 2004-08-11 Decode Genetics EHF Non-inclusion cyclodextrin complexes
FR2834212B1 (fr) 2001-12-27 2004-07-09 Besins Int Belgique Utilisation d'une poudre a liberation immediate dans des compositions pharmaceutiques et nutraceutiques
BR0307518A (pt) 2002-02-01 2004-12-28 Shimoda Biotech Pty Ltd Composição farmacêutica
EP1476135A1 (en) 2002-02-22 2004-11-17 Pharmacia Corporation Ophthalmic formulation with gum system
US6869939B2 (en) 2002-05-04 2005-03-22 Cydex, Inc. Formulations containing amiodarone and sulfoalkyl ether cyclodextrin
CN1232539C (zh) * 2002-05-10 2005-12-21 刘云清 有机药物与倍他环糊精衍生物的配合物及其制备方法
AU2003241464A1 (en) 2002-05-17 2003-12-02 Eisai Co., Ltd. Compositions and methods using proton pump inhibitors
DE60319221T2 (de) 2002-06-13 2009-03-05 Novartis Ag Quaternisierte ammoniumcyclodextrinverbindungen
FR2842736B1 (fr) 2002-07-26 2005-07-22 Flamel Tech Sa Formulation pharmaceutique orale sous forme d'une pluralite de microcapsules permettant la liberation prolongee de principe(s) actif(s) peu soluble(s)
US7148211B2 (en) 2002-09-18 2006-12-12 Genzyme Corporation Formulation for lipophilic agents
NZ540318A (en) 2002-10-31 2007-09-28 Umd Inc Therapeutic compositions for drug delivery to and through covering epithelia
BR0316673A (pt) 2002-11-27 2005-10-18 Pharmacia Corp Composição lìquida concentrada de valdecoxib
US20060134095A1 (en) 2003-01-27 2006-06-22 Shinobu Ito Antioxidative composition and composition for external use
EP2191846A1 (en) 2003-02-19 2010-06-02 Rinat Neuroscience Corp. Method for treating pain by administering a nerve growth factor antagonist and an NSAID and composition containing the same
AU2004219595A1 (en) 2003-03-11 2004-09-23 Qlt Usa Inc. Formulations for cell- schedule dependent anticancer agents
US20050085446A1 (en) 2003-04-14 2005-04-21 Babu M.K. M. Fluoroquinolone formulations and methods of making and using the same
US20070049552A1 (en) 2003-04-14 2007-03-01 Babu Manoj M Fluoroquinolone formulations and methods of making and using the same
TW575271U (en) * 2003-06-25 2004-02-01 Wen-Chin Fan Three-dimensional picture exhibiting device of image display
WO2005042026A1 (ja) 2003-10-31 2005-05-12 Wakamoto Pharmaceutical Co., Ltd. 可逆性熱ゲル化水性組成物
US20050095205A1 (en) 2003-10-31 2005-05-05 Ramesh Krishnamoorthy Combination of loteprednol etabonate and tobramycin for topical ophthalmic use
US20050197303A1 (en) 2003-10-31 2005-09-08 Bausch & Lomb Incorporated Combination of loteprednol etabonate and tobramycin for topical ophthalmic use
WO2005074887A2 (en) 2004-01-30 2005-08-18 Rutgers, The State University Amphiphilic star-like or scorpion-like macromolecules, various compositions and uses thereof
KR20050081092A (ko) 2004-02-12 2005-08-18 한국과학기술연구원 생체적합성 친수성 고분자를 포함하는 콜로이드계 조성물,제형 및 이들의 제조 방법
US20050203115A1 (en) 2004-03-10 2005-09-15 Sancilio Frederick D. Narcotic-NSAID ion pairs
DK1574221T3 (da) 2004-03-10 2007-07-16 Shimoda Biotech Pty Ltd Stabile, injicérbare diclofenacsammensætninger
DE102004017351A1 (de) * 2004-04-08 2005-10-27 Kalle Gmbh Schlauchförmige Nahrungsmittelhülle mit übertragbarer Innenschicht
EP1761283A2 (en) 2004-06-07 2007-03-14 California Institute Of Technology Biodegradable drug-polymer delivery system
US20090035315A1 (en) 2004-06-17 2009-02-05 Stephan Christgau Method of Improving Treatments in Rheumatic and Arthritic Diseases
ITMI20041245A1 (it) 2004-06-22 2004-09-22 Ibsa Inst Biochimique Sa Composizioni farmaceutiche iniettabnili comprendenti diclofenac sodico e b-ciclodestrina
TWI279226B (en) 2004-07-20 2007-04-21 Schoeller Textil Ag Dressings which can be applied several times to textile fibres and textile fabrics
GB2417900A (en) 2004-09-11 2006-03-15 Medway Science Technologies Lt Composition for oral drug delivery
BRPI0516308A2 (pt) 2004-10-04 2010-06-15 Qlt Usa Inc composição fluida, métodos de tratamento de uma doença ou disfunção, métodos de liberação local ou sistêmica de um agente biológico, implantes, método de formação de um implante, kit de agente biológico e usos de uma composição fluida
DE602005027727D1 (de) 2004-10-15 2011-06-09 Seo Hong Yoo Zusammensetzungen zur verringerung der toxizität von cisplatin, carboplatin und oxaliplatin
WO2006082588A2 (en) 2005-02-07 2006-08-10 Pharmalight Inc. Method and device for ophthalmic administration of active pharmaceutical ingredients
US7140694B2 (en) * 2005-03-29 2006-11-28 Steven Mason Wheel spoke adjuster guard
KR101255650B1 (ko) * 2005-05-04 2013-04-16 프로노바 바이오파마 너지 에이에스 새로운 dha 유도체 및 약제로서의 용도
CN103145839A (zh) 2005-06-30 2013-06-12 Abbvie公司 Il-12/p40结合蛋白
CA2613875C (en) 2005-07-04 2018-09-25 Ramu Krishnan Improved drug or pharmaceutical compounds and a preparation thereof
US9198862B2 (en) 2005-07-22 2015-12-01 Rubicon Research Private Limited Dispersible tablet composition
RU2008124805A (ru) 2005-11-21 2009-12-27 Шеринг-Плоу Лтд. (CH) Фармацевтические композиции, содержащие бупренорфин
US9757455B2 (en) 2005-11-28 2017-09-12 Johnson & Johnson Consumer Inc. Oral therapeutic compound delivery system
US8435965B2 (en) 2005-12-27 2013-05-07 Lion Corporation Composition for soft contact lens and adsorption suppressing method
WO2007103687A2 (en) 2006-03-01 2007-09-13 Tristrata, Inc. Composition and method for topical treatment of tar-responsive dermatological disorders
WO2007103435A2 (en) 2006-03-06 2007-09-13 The Regents Of The University Of California Bioavailable curcuminoid formulations for treating alzheimer's disease and other age-related disorders
US7767217B2 (en) 2006-03-14 2010-08-03 Foresight Biotherapeutics Ophthalmic compositions comprising povidone-iodine
KR20090010953A (ko) 2006-03-28 2009-01-30 자블린 파머슈티칼스 인코포레이티드 저 복용량의 비-스테로이드성 항염증성 약물 및 베타-사이클로덱스트린 제형
US8580954B2 (en) * 2006-03-28 2013-11-12 Hospira, Inc. Formulations of low dose diclofenac and beta-cyclodextrin
WO2008006216A1 (en) 2006-07-14 2008-01-17 Mistral Pharma, Inc. Anti-inflammatory and cytoprotectant chronotherapy
CA2914170C (en) 2006-09-08 2018-10-30 Abbvie Bahamas Ltd. Interleukin-13 binding proteins
CN105168186A (zh) 2006-10-02 2015-12-23 Apr应用制药研究股份公司 非粘膜粘着性膜剂型
EP2511844B1 (en) 2006-10-10 2015-08-12 XRpro Sciences, Inc. X-ray microscope
FI20065800A0 (fi) 2006-12-13 2006-12-13 Glykos Finland Oy Polyvalentit biokonjugaatit
EP2120962A1 (en) 2006-12-18 2009-11-25 Allergan, Inc. Methods and compositions for treating gastrointestinal disorders
US20100166870A1 (en) 2006-12-21 2010-07-01 The University Of Western Australia Method for Coating Nanoparticles
WO2008115572A1 (en) 2007-03-21 2008-09-25 Theraquest Biosciences, Inc. Methods and compositions of nsaids
EP1974751A1 (en) 2007-03-26 2008-10-01 The Jordanian Pharmaceutical Manufacturing Co. Formulations for non-steroidal anti-inflammatory drugs
CN101686681B (zh) 2007-04-27 2015-04-01 锡德克斯药物公司 包含氯吡格雷和磺基烷基醚环糊精的制剂和其使用方法
WO2008133982A2 (en) 2007-04-27 2008-11-06 Lectec Corporation Adhesive patch with aversive agent
US7662858B2 (en) 2008-05-23 2010-02-16 Aaipharma, Inc. Method of treating post-surgical acute pain
MY166036A (en) * 2011-07-20 2018-05-21 Hospira Inc Methods of treating pain

Similar Documents

Publication Publication Date Title
JP2009531450A5 (https=)
JP5823093B2 (ja) 低投与量のジクロフェナク及びβ−シクロデキストリンの配合物
JP2013505205A5 (https=)
JP2019131596A5 (https=)
RU2012134321A (ru) Анестезирующий состав
JP2011251975A5 (https=)
JP2012520866A5 (https=)
JP2014528474A5 (https=)
JP2010525059A5 (https=)
WO2007112274A3 (en) Formulations of low dose non-steroidal anti-inflammatory drugs and beta-cyclodextrin
JP2012520343A5 (https=)
JP2013540824A5 (https=)
WO2007106550A3 (en) Methods and compositions for deterring abuse of orally administered pharmaceutical products
JP2012514021A5 (https=)
NZ587202A (en) Methods for measuring a patient response upon administration of a drug and compositions thereof
WO2008146016A3 (en) Cyclodextrins for administering fatty acids in tablets
JP2012517449A5 (https=)
HRP20170021T1 (hr) Formulacije koje sadrže 2-amino-2-[2-(4-oktilfenil)etil]propan-1,3-diol
MX2008013829A (es) Uso de compuestos de la formula a-r-x o sus sales farmaceuticas tolerables para producir una preparacion farmaceutica.
HRP20131150T1 (hr) Pimobendan za uporabu u lijeäśenju hipertrofiäśne kardiomiopatije kod maäśaka
JP2009513663A5 (https=)
JP2018506533A5 (https=)
AR061477A1 (es) Metodos para utilizar un derivado de tiazol
IL300144A (en) Benzazepines are combined for the treatment of Tourette syndrome
JP2009514963A5 (https=)